Who We Are

Our mission is to improve the quality of life of patients around the world through the development and delivery of high quality, innovative and easy to use therapeutic solutions.

Our Evolution

Our rebrand is inspired by the koru, a widely recognized symbol of a spiral-shaped, unfurling fern representative of new life and new beginnings. Koru Medical Systems is focused on providing patients their new beginnings with our at-home infusion systems being the heart of our brand.

KORU is, first and foremost, a patient-oriented company that goes the extra mile for our customers and the patients who depend on our devices. Our team is comprised of talented, caring individuals who are keen to employ individualized perspectives to our business and strategy. Our revamping as a company reflects the great strides we have made in evolving our corporate culture, mission, and philosophy to a more patient-centric focus.

Our Company Shared Values


in each other


in everything we do


for actions and results

Market Driven

decision making


to learn and grow

Open Minded

to new ideas and change


for self and others


of our business and goal

Our Story

Repro Med Systems, Inc., now operating as KORU Medical Systems, is a leading developer and manufacturer of medical devices and supplies. We focus on home and specialty infusion solutions, emphasizing responsive problem-solving for our customers with careful consideration to the patient experience. The company was incorporated in March 1980 and is now publicly traded on the NASDAQ Capital Market (NASDAQ: KRMD). We are located in Chester, NY (USA), just 60 miles northwest of New York City.

Our primary products include the Freedom Integrated Infusion System: the FREEDOM60® and FreedomEdge® Syringe Drivers, Precision Flow Rate Tubing™, and HIgH-Flo Subcutaneous Safety Needle Sets™

Worldwide, KORU Medical Systems drives healthcare inspiration – in the minds of our patients, our employees, our customers, and our shareholders – to give everyone greater freedom for living. Our products and customer service support are offered throughout the world through a global network of distributors and service providers. We design and manufacture safe, affordable medical devices to make quality healthcare a reality for everyone.

We are excited to expand into new markets with innovative, technical products. We look forward to productive partnerships with people and companies who share our vision and can help us effectively deliver our value promise to stakeholders in our industry.

President and Chief Executive Officer

Donald B. Pettigrew

President and Chief Executive Officer

Mr. Pettigrew has more than 23 years of sales and business development experience in the medical device industry, including the home infusion space. Prior to joining RMS (now KORU Medical Systems) as President and Chief Commercial Officer in 2018, Mr. Pettigrew held senior leadership positions at market-leading medical firms such as Moog, Inc. as Global Business Development and Group Director, Global Sales and Professional Services from 2011 through 2018, where he led commercialization and business development for the IV infusion and enteral feeding franchises in both the U.S. and international markets. Mr. Pettigrew also held management positions at Baxter (formerly Gambro) from 2008-2011, Boston Scientific from 1995-2008, and E&J Gallo from 1990-1995. Mr. Pettigrew earned his B.A. in Biology from the University of Colorado.

Chief Financial Officer

Karen Fisher

Chief Financial Officer

Karen Fisher has more than 25 years of financial experience in a variety of industries, most recently serving as the Assistant Controller for a global consumer products company. She has also held roles such as Chief Accounting Officer and Treasurer, and Controller. Ms. Fisher held multiple financial management roles covering financial analysis and reporting, budgeting, forecasting, acquisitions, and cash management. She is thoroughly knowledgeable in compliance with SEC regulation, GAAP, 10Q’s, 10K’s and Sarbanes-Oxley. Ms. Fisher is a Certified Public Accountant and a graduate of Arizona State University with a BS in Accounting.

Chief Operating Officer

Manuel Marques

Chief Operating Officer

Manny Marques has an engineering background in FDA Class II & III medical devices. He has a proven history of effectively transferring new products from R&D into manufacturing, while also reducing operating and manufacturing costs of existing products. Mr. Marques is a champion at enhancing operational management via implementation of Lean 6-Sigma Manufacturing techniques. Mr. Marques holds two U.S. patents for cardiovascular medical devices. Manny obtained a BS in Mechanical Engineering Technology and also an MS in Engineering Management from the New Jersey Institute of Technology.

Vice President of Medical Affairs

Brian Schiller, PhD

Vice President of Medical Affairs

Brian Schiller, PhD, is a senior leader with diverse medical affairs and clinical research experience spanning global strategic development, product launch, legal, regulatory and compliance alignment, recruitment and leadership of field medical teams, professional medical education, publication planning and medical communication strategy, company- and investigator-sponsored clinical research, medical marketing and health outcomes research. He has demonstrated success across a wide array of specialty areas including internal medicine, cardiology, endocrinology, immunology, neurology/neuropsychiatry, dermatology, orthopedics, general and gynecologic surgery.

Prior to joining RMS (now KORU Medical Systems), Dr. Schiller was Senior Director and Head of Field Medical, North America Medical Affairs at Sanofi (Genzyme) since 2009. From 2005-2008 Dr. Schiller worked at Avanir Pharmaceuticals; initially as an Associate Director of Medical Affairs, and later as Associate Director of Clinical Research and Medical Affairs. Dr. Schiller also held leadership roles at Amgen from 2002-2005 and at Bristol Myers Squibb from 1999-2002.

Vice President of Growth and Innovation

John Toomey

Vice President of Growth and Innovation

John Toomey brings with him over 30 years of medical device industry experience as an executive, patent officer, inventor, board member, and advisor. Mr. Toomey holds 24 U.S. and foreign patents.

Mr. Toomey will be responsible for research and development, product innovation, and business development, as well as integrating these capabilities across the enterprise. He will also play a key role in building a robust IP platform. Mr. Toomey has held leadership roles at numerous medical device companies, including Pneuma Systems Corporation, Validose, Inc., Halkey-Roberts Corporation, Smith’s Medical, Inc., and CR Bard (acquired by Becton Dickinson). He also founded 2ME Mgmt Consultancy, LLC, which specialized in developing latent market opportunities and solving project, regulatory, and IP challenges in the medical device space.

Mr. Toomey received his BS from Allegheny College, MBA from the Marshall School of Business at the University of Southern California, and JD from Thomas Jefferson School of Law.

Join Our Team

We are always looking for dedicated, hard-working team members. If you have the skills and are seeking a challenging growth opportunity, please view our job postings below.

All Positions Offer Opportunity for Advancement

KORU offers a competitive salary and benefits package, including medical, dental, LTD and 401(k).

Current Openings